Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL KETOROLAC INDUSTRY
2.1 Summary about Ketorolac Industry
2.2 Ketorolac Market Trends
2.2.1 Ketorolac Production & Consumption Trends
2.2.2 Ketorolac Demand Structure Trends
2.3 Ketorolac Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tables
4.2.2 Injection
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Medical Uses
4.3.2 Chemistry Uses
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tables
5.2.2 Injection
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Medical Uses
5.3.2 Chemistry Uses
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tables
6.2.2 Injection
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Medical Uses
6.3.2 Chemistry Uses
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tables
7.2.2 Injection
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Medical Uses
7.3.2 Chemistry Uses
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tables
8.2.2 Injection
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Medical Uses
8.3.2 Chemistry Uses
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tables
9.2.2 Injection
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Medical Uses
9.3.2 Chemistry Uses
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Allergan
10.1.2 DeepCare Health
10.1.3 Cadila
10.1.4 FDC
10.1.5 Intas Laboratories
10.1.6 Gufic Chem
10.1.7 Ranbaxy
10.1.8 Adley Formulation
10.1.9 Neon Laboratories
10.1.10 Sun Pharmaceutical Industries
10.1.11 Cipla
10.1.12 Dallas Pharmaceuticals
10.1.13 Nicholas Piramal India
10.1.14 AHPL
10.2 Ketorolac Sales Date of Major Players (2017-2020e)
10.2.1 Allergan
10.2.2 DeepCare Health
10.2.3 Cadila
10.2.4 FDC
10.2.5 Intas Laboratories
10.2.6 Gufic Chem
10.2.7 Ranbaxy
10.2.8 Adley Formulation
10.2.9 Neon Laboratories
10.2.10 Sun Pharmaceutical Industries
10.2.11 Cipla
10.2.12 Dallas Pharmaceuticals
10.2.13 Nicholas Piramal India
10.2.14 AHPL
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT